• Aumenta el tamaño del texto
  • Disminuye el tamaño del texto
  • Imprimir

IRB Barcelona News - Institutional


  • 9 July 2014
    The scientific community does not give up its fight against Alzheimer’s disease

    Around 160 scientists, brought together by IRB Barcelona and the BBVA Foundation in a Barcelona Biomed Conference, are discussing the latest research into one of the hallmarks of Alzheimer’s disease, the amyloid-beta protein that is the major component of the plaques that are characteristic of this debilitating disorder.

    According to data from Alzheimer's Disease International in 2013, an estimated 135 million people worldwide will be suffering from dementia in 2050, Alzheimer’s disease being the most prevalent. This condition currently affects over 40 million people but is very strongly age-related, giving rise to the prospect of a ‘21st century plague’ affecting the aging populations across the globe.

    A recent report from the Cleveland Clinic published in July 3, indicates that 99.6% of the clinical trials for Alzheimer´s disease have failed, with the result that much of the pharmaceutical industry is discouraged and uncertain as to how to proceed. The scientific community, however, is making substantial progress in understand the underlying causes of the disease, an essential factor in the rational design of innovative therapeutic strategies.

  • 20 June 2014
    IRB to participate in the international biotech fair par excellence

    Twenty-two companies and four institutes form the Catalan delegation organised by Biocat for the San Diego gathering.

  • 3 June 2014
    ICREA Academia Award for Antonio Zorzano

    IRB hosts 13 researchers who have received the ICREA seal of recognition

  • 2 June 2014
    Joan Massagué. 2014 National Culture Award

    Today the cofounder and current president of the International Scientific Board of IRB receives the highest recognition in the field of culture in Catalonia

  • 31 May 2014
    More than 300 people participate in the charity wine-tasting ‘Vi per Vida’ to raise funds for research into metastasis
  • 26 May 2014
    Eduard Batlle to analyse the most advanced cancer research in the business forum Primera Plan@

    The coordinator of the Oncology Programme at IRB Barcelona will also share his vision of the challenges and opportunities faced by Catalonia in order to maintain its leadership in global science.

    Organised by “El Periódico de Catalunya” and with the support of the “Banco Sabadell”, the Primera Plan@ conferences are attended by distinguished managing directors, academics, lawyers, researchers, and representatives from the financial and social sectors and trade unions.

  • 21 May 2014
    Salvador Aznar Benitah awarded the Bank of Sabadell Prize for Biomedical Research for his studies on stem cells and cancer

    • ICREA researcher at IRB Barcelona, Salvador Aznar Benitah (Montreal, Canada), studies how human tissue regenerates, why they age, and why tumours develop over time, with a special focus on skin and the oral mucosa.

    • In 2010, another IRB Barcelona researcher, Eduard Batlle, coordinator of the Oncology Programme and head of the Colorectal Cancer Lab, received the same prize.

  • 16 May 2014
    Bringing together science and companies

    “Cafè amb la Recerca” (Research over a coffee), organised by the “Fundació Catalana per a la Recerca i la Innovació”, seeks to offer a meeting point in which research centres, companies, and investors can explore collaboration initiatives.

    In the first session of this series, Joan J. Guinovart, director of the IRB Barcelona and Josep Samitier, director of the IBEC presented their research lines to eight managerial representatives from the business and investment sectors.

  • 12 May 2014
    IRB launches Maths4Life to train biostatisticians

    This initiate is aimed at young undergraduate students and graduates in statistics, mathematics, informatics, and bioinformatics interested in the biosciences.

    Maths4Life involves tutored summer training placements in labs working in cancer, network biology, molecular modelling and biostatistics.

  • 29 April 2014
    The charity initiative “Vi per Vida” (Wine for Life) is launched to support research into metastasis

    • Promoted by the Catalan sommelier Xavi Ayala (34 years old), the newly founded charity organisation is running the “I Tast Solidari Vi per Vida” (I “Wine for Life” Charity Tasting) for 500 people on 31 May in Mollerussa.

    • The “Institut Català de la Vinya i el Vi”, INCAVI, the Mollerussa Town Council, Carlos Latre, the Roca brothers, Empar Moliner, and Pilarín Bayés, among other popular figures, have joined the initiative.

    • The donations from in this first wine tasting event will be given to the Institute for Research in Biomedicine (IRB), Barcelona, a centre that develops projects endorsed by Joan Massagué, co-founder of IRB and international expert in research into metastasis.

    • 90% of deaths from cancer are caused by metastasis, a process through which tumour cells escape from the original tumour towards other organs, generating new tumours.

News search

News search

Press Office

  • Sònia Armengou
    Media relations
    Tel:+34 93 403 72 55
    Fax:+34 93 403 71 14
    sonia.armengouarrobairbbarcelona.org
Trustees:
  • Generalitat de catalunya
  • Generalitat de catalunya. Salut
  • Universidad de Barcelona
  • Fundación BBVA

Institute for Research in Biomedicine (IRB Barcelona)

Parc Científic de Barcelona Parc Científic de Barcelona

C/ Baldiri Reixac 10
08028 Barcelona - Spain
Tel: +34 93 402 02 50 | Fax: +34 93 403 71 14
infoarrobairbbarcelona.org